SAN DIEGO, Aug. 26 /PRNewswire-FirstCall/ — CareFusion (NYSE:
CFN), a leading, global medical device company, today announced
the national commercial launch of the AVAmax® Vertebral
Balloon, a minimally invasive device for use during kyphoplasty, a
procedure for treating spinal compression fractures.
The AVAmax Vertebral Balloon represents a competitive
breakthrough and is expected to enhance the affordability of spinal
fracture procedures. CareFusion’s vertebral balloon product and
related components cost up to 40 percent less than similar
kyphoplasty products on the market today, making the procedure more
cost effective and accessible to hospitals and outpatient surgery
centers.
During the product’s limited release period, CareFusion
completed approximately 300 case studies with eight in 10
physicians saying they would strongly consider switching to the
AVAmax product, according to post-product evaluation
surveys.
The AVAmax Vertebral Balloon is part of an all-in-one
system that includes an eight-gauge or 10-gauge needle, bone cement
and delivery instruments for kyphoplasty or vertebroplasty, an
alternate procedure to treat compression fractures. The all-in-one
system gives doctors the choice and flexibility to perform either
procedure at the time of patient care.
“The AVAmax Vertebral Balloon is easier to use and more
efficiently designed than the system previously available to me,”
said C. Douglas Edmondson, M.D., FACR, Interventional Radiologist
at Medical Center of South Arkansas. “With one more tool in the
AVAmax toolbox, I can more selectively tailor spinal
interventions with vertebropasty or kyphoplasty with a huge cost
savings and no wasted materials.”
The AVAmax® PLUS vertebral augmentation system, which
delivers cement for the procedure, allows the radiologist’s hands
to
‘/>”/>
